These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

571 related items for PubMed ID: 9885719

  • 1. Botulinum toxin for neurological disorders in a movement disorders clinic in Singapore.
    Tan AK.
    Singapore Med J; 1998 Sep; 39(9):403-5. PubMed ID: 9885719
    [Abstract] [Full Text] [Related]

  • 2. Safety, effectiveness, and duration of effect of BOTOX after switching from Dysport for blepharospasm, cervical dystonia, and hemifacial spasm dystonia, and hemifacial spasm.
    Bihari K.
    Curr Med Res Opin; 2005 Mar; 21(3):433-8. PubMed ID: 15811212
    [Abstract] [Full Text] [Related]

  • 3. Five-year experience in the treatment of focal movement disorders with low-dose Dysport botulinum toxin.
    Van den Bergh P, Francart J, Mourin S, Kollmann P, Laterre EC.
    Muscle Nerve; 1995 Jul; 18(7):720-9. PubMed ID: 7783762
    [Abstract] [Full Text] [Related]

  • 4. Botulinum toxin in the treatment of dystonias--a hospital based study.
    Gupta M, Singh G, Khwaja G.
    J Assoc Physicians India; 2003 May; 51():447-53. PubMed ID: 12974424
    [Abstract] [Full Text] [Related]

  • 5. Effectivity of Dysport in patients with blepharospasm and hemifacial spasm who experienced failure with Botox.
    Badarny S, Susel Z, Honigman S.
    Isr Med Assoc J; 2008 Jul; 10(7):520-2. PubMed ID: 18751631
    [Abstract] [Full Text] [Related]

  • 6. What is new in the era of focal dystonia treatment? Botulinum injections and more.
    Cetinkaya A, Brannan PA.
    Curr Opin Ophthalmol; 2007 Sep; 18(5):424-9. PubMed ID: 17700237
    [Abstract] [Full Text] [Related]

  • 7. Botulinum toxin in movement disorders.
    Papapetropoulos S, Singer C.
    Semin Neurol; 2007 Apr; 27(2):183-94. PubMed ID: 17390263
    [Abstract] [Full Text] [Related]

  • 8. Botulinum toxin in the treatment of writer's cramp.
    Behari M.
    J Assoc Physicians India; 1999 Jul; 47(7):694-8. PubMed ID: 10778589
    [Abstract] [Full Text] [Related]

  • 9. [Botulinum toxin A: experience in the treatment of 115 patients].
    Andrade LA, Borges V, Ferraz HB, Azevedo-Silva SM.
    Arq Neuropsiquiatr; 1997 Sep; 55(3B):553-7. PubMed ID: 9629404
    [Abstract] [Full Text] [Related]

  • 10. Botulinum toxin treatment of hemifacial spasm and blepharospasm: objective response evaluation.
    Thussu A, Barman CR, Prabhakar S.
    Neurol India; 1999 Sep; 47(3):206-9. PubMed ID: 10514580
    [Abstract] [Full Text] [Related]

  • 11. Adult-onset focal dystonias: presentation and treatment options.
    Esper GJ, Charles PD, Davis TL, Robertson D.
    Tenn Med; 1997 Jan; 90(1):18-20. PubMed ID: 8997156
    [Abstract] [Full Text] [Related]

  • 12. [Clinical symptoms, diagnosis and treatment of focal dystonias].
    Klivényi P, Vécsei L.
    Orv Hetil; 2001 Oct 21; 142(42):2293-7. PubMed ID: 11760645
    [Abstract] [Full Text] [Related]

  • 13. Prospective, randomized, double-blind study, comparing botulinum toxins type a botox and prosigne for blepharospasm and hemifacial spasm treatment.
    Quagliato EM, Carelli EF, Viana MA.
    Clin Neuropharmacol; 2010 Oct 21; 33(1):27-31. PubMed ID: 20124784
    [Abstract] [Full Text] [Related]

  • 14. [Treatment of movement disorders using botulinum toxin].
    Burgunder JM.
    Schweiz Med Wochenschr; 1992 Sep 05; 122(36):1311-6. PubMed ID: 1411387
    [Abstract] [Full Text] [Related]

  • 15. Quantitative assessment of efficacy of dysport (botulinum toxin type A) in the treatment of idiopathic blepharospasm and hemifacial spasm.
    Tsai CP, Chiu MC, Yen DJ, Guo YC, Yuan CL, Lee TC.
    Acta Neurol Taiwan; 2005 Jun 05; 14(2):61-8. PubMed ID: 16008164
    [Abstract] [Full Text] [Related]

  • 16. Restoring balance in focal limb dystonia with botulinum toxin.
    Sheean G.
    Disabil Rehabil; 2007 Dec 15; 29(23):1778-88. PubMed ID: 18033603
    [Abstract] [Full Text] [Related]

  • 17. Long-term efficacy of botulinum toxin A in treatment of various movement disorders over a 10-year period.
    Hsiung GY, Das SK, Ranawaya R, Lafontaine AL, Suchowersky O.
    Mov Disord; 2002 Nov 15; 17(6):1288-93. PubMed ID: 12465070
    [Abstract] [Full Text] [Related]

  • 18. [Therapy of dystonia in Japan].
    Mezaki T, Hayashi A, Nakase H, Hasegawa K.
    Rinsho Shinkeigaku; 2005 Sep 15; 45(9):634-42. PubMed ID: 16248394
    [Abstract] [Full Text] [Related]

  • 19. Localized injections of botulinum toxin for the treatment of focal dystonia and hemifacial spasm.
    Brin MF, Fahn S, Moskowitz C, Friedman A, Shale HM, Greene PE, Blitzer A, List T, Lange D, Lovelace RE.
    Mov Disord; 1987 Sep 15; 2(4):237-54. PubMed ID: 3504553
    [Abstract] [Full Text] [Related]

  • 20. Blepharospasm and hemifacial spasm: a protocol for titration of botulinum toxin dose to the individual patient and for the management of refractory cases.
    Ortisi E, Henderson HW, Bunce C, Xing W, Collin JR.
    Eye (Lond); 2006 Aug 15; 20(8):916-22. PubMed ID: 16531977
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 29.